- Report
- March 2023
- 479 Pages
Europe
From €8187EUR$8,995USD£6,954GBP
- Report
- February 2019
United States
From €4091EUR$4,495USD£3,475GBP
From €3186EUR$3,500USD£2,706GBP
- Report
- May 2023
- 89 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- May 2023
- 83 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- January 2025
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- March 2022
- 236 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
The Bare Metal Stent (BMS) market is a subset of the larger stent market. BMS are medical devices used to treat narrowed or blocked arteries. They are made of stainless steel or cobalt chromium and are designed to be inserted into the artery to keep it open. BMS are used to treat a variety of conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. BMS are typically used in combination with other treatments, such as angioplasty or bypass surgery.
BMS are considered to be a cost-effective treatment option for many patients, as they are less expensive than other stent types. They are also less invasive than other treatments, making them a popular choice for many patients.
Some of the major companies in the BMS market include Abbott, Boston Scientific, Medtronic, and Biotronik. Show Less Read more